BioSpace News Archive

Pipeline offers critical “one-two punch” in potential treatment arsenal for Alzheimer’s disease

Eli Lilly and Company announced a license agreement to acquire the exclusive worldwide rights for CNTX-0290 from Centrexion Therapeutics Corporation, a company focused on developing non-opioid, non-addictive therapeutics for the treatment of chronic pain.

SOURCE EXPLORER announced that it has accumulated over 3,000 clients and is taking a firm launch into the global marketplace.

Gross to head national leader in travel nurse staffing

First Conference of Its Kind to Bring Together Patients, Survivors, Caregivers, Non-Profits, Healthcare Providers, Hospital Systems and Industry Professionals

Canopy Growth Corporation is pleased to announce the next phase in its partnership with Parent Action on Drugs and Canadian Students for Sensible Drug Policy which will see PAD launch two new digital tools to help youth along with their parents, adult caregivers, and influencers, on how to make responsible decisions about cannabis use.

Technique Aims to Preserve the Original Nose Structure as Possible

Liquid biopsy data reveals “intriguing” association between ESR1 mutations, HER2 alterations and prognosis

Presentation to highlight Enteris’ development pipeline, led by Ovarest®, the company’s oral leuprolide product for the treatment of endometriosis

It was a very significant week for Novadoz Pharmaceuticals, the U.S sales & marketing affiliate of The MSN Group based in Hyderabad, India.